BPA

Published January 25, 2021 Find resources and tools for understanding tumor-specific response and resistance to cancer immunotherapies.   Overview What is immunotherapy? The role of the immune system Flexible, validated research solutions Key targets involved in tumor resistance: STING, IDO1, and VISTA STING IDO1 VISTA New flow cytometry antibodies to support the studies of live cells Antibody panels to increase your chance of success Advancing immuno-oncology research, together What is immunotherapy? Immunotherapy is a revolutionary approach to cancer treatment that helps…

w/ Jeppe Thagaard, Visiopharm Machine learning is not a new technology, but it started to revolutionize pathology relatively recently. The ideal combination of untapped, abundant pathology data necessary to leverage machine learning and the relevance of pathology applications has drawn scientists to this field and caused an artificial intelligence (AI) explosion. Within just two years from 2018 to 2020 AI-based tissue image analysis went from “cutting edge technology” to “mainstream”. The deep learning explosion started with the Camelyon challenge which served as…

Seeds of immune destruction‐mini electric shocks in mitochondria: Neuroplasticity‐electrobiology of response profiles and increased induced diseases in four generations – A hypothesis From: Mahin Khatami First published: 19 December 2020 https://doi.org/10.1002/ctm2.215 Abstract From Rockefeller’s support of patent medicine to Gates’ patent vaccines, medical establishment invested a great deal in intellectual ignorance. Through the control over medical education and research it has created a public illusion to prop up corporate profit and encouraged the lust for money and power. An overview of…

The Corona Simulation Machine: Why the Inventor of The “Corona Test” Would Have Warned Us Not To Use It To Detect A Virus “Scientists are doing an awful lot of damage to the world in the name of helping it. I don’t mind attacking my own fraternity because I am ashamed of it.” –Kary Mullis, Inventor of Polymerase Chain Reaction What do we mean when we say somebody has ‘tested positive’ for the Corona Virus? The answer would astound you.…

In memory of Professor Juan Rosai Juan Rosai, M.D. (August 1940 – July 2020)  Despite all the advances in molecular pathology and other disciplines, the diagnosis of solid tumours today is still based in the overwhelming majority of the cases on what we see under the microscope. Juan Rosai was born in Italy as World War II began and emigrated with his family to Argentina at the age of eight.  He fulfilled his immigrant parents’ ‘dream’ by becoming a doctor. …